<DOC>
	<DOCNO>NCT00492232</DOCNO>
	<brief_summary>The purpose study ass whether ramelteon , daily ( QD ) , facilitate discontinuation zolpidem subject chronic insomnia .</brief_summary>
	<brief_title>Facilitation Zolpidem ( â‰¥10 mg ) Discontinuation Through Use Ramelteon Subjects With Chronic Insomnia</brief_title>
	<detailed_description>Approximately 60 70 million adult United States alone affect insomnia . Daytime symptoms insomnia include tiredness , lack energy , difficulty concentrating , irritability . Recent epidemiologic research focus quality life identify significant insomnia-related morbidity relate work productivity , health care utilization , risk depression . Insomnia associate diminished work output , absenteeism , great rate accident . Zolpidem commonly prescribe hypnotic United States patient suffer insomnia . The purpose study ass whether ramelteon therapy facilitate discontinuation benzodiazepine therapy long term user . Subject participation study anticipate 17 week . Subjects screen enrolled 4-week placebo run-in period , may randomize 10-week double-blind treatment period , may complete 2-week open-label treatment period . In double-blind treatment period , subject randomize one two treatment : either ramelteon 8 mg tablet take orally once-daily concomitant current zolpidem therapy placebo-matching tablet daily concomitant current zolpidem therapy . Subjects incrementally reduce zolpidem therapy dose , frequency , 10 week . Only subject complete double-blind treatment period achieve 50 % reduction zolpidem therapy double-blind treatment period participate open-label treatment period 8 mg ramelteon administer . Zolpidem consume open-label treatment period record .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Inclusion Criteria Chronic insomnia take great equal 10 mg zolpidem least 4 time per week . Has prescribe zolpidem difficulty initiate sleep . Must report chronic use zolpidem great equal to10 mg therapy minimum 3 month prior entry Period 1 study . Must take zolpidem great equal 10 mg therapy least 4 7 day week 4 week immediately prior entry double blind phase , Period 2 . Expressed willingness discontinue zolpidem therapy . Habitual bedtime 9:00 PM 1:00 AM base sleep history . Negative test result hepatitis B surface antigen hepatitis C virus antibody . Females childbearing potential sexually active must agree use adequate contraception , neither pregnant lactating Screening throughout duration study . Exclusion Criteria Known hypersensitivity ramelteon , zolpidem , melatonin . Participated investigational study and/or take investigational drug within 30 day prior first dose runin study medication . Sleep schedule change require employment ( eg , shift worker ) within 3 month prior first night runin study medication . History fibromyalgia , history seizure , sleep apnea , restless leg syndrome , periodic leg syndrome , chronic obstructive pulmonary disease , schizophrenia , bipolar disorder , mental retardation , cognitive disorder . History drug addiction drug abuse within past 12 month . History alcohol abuse within past 12 month , define Diagnostic Statistical Manual Mental Disorders , 4th Edition revise and/or regularly consume 2 alcoholic drink per day . Current significant hepatic , renal , endocrine , cardiovascular , gastrointestinal , pulmonary , hematological , metabolic disease , unless currently control stable protocolallowed medication , within 30 day prior first night runin study medication . Body mass index less 18 great 34 ( weight /height2 ) . Any clinically important abnormal finding document medical history , physical examination , electrocardiogram , clinical laboratory test , determine investigator . Positive hepatitis panel . Known history human immunodeficiency virus . Any additional condition ( ) investigator 's opinion would affect : sleep/wake function prohibit subject complete study indicate continuation study would best interest subject . Is required take continue take disallow medication , prescription medication , herbal treatment overthe counter medication , include : Melatonin Anxiolytics Antipsychotics Overthecounter prescription sedative Hypnotics ( exclude zolpidem ) Narcotic analgesic Antidepressants Betablockers ( exception Atenolol permissible ) Anticonvulsants St. John 's wort Sedating H1 antihistamines Kavakava Systemic steroid Ginkgobiloba Respiratory stimulant Overthecounter prescription diet aid Sedating Decongestants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Chronic Insomnia</keyword>
	<keyword>Sleep Initiation Maintenance Disorder</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>